5th Circuit Bans Mifepristone Mail Distribution; Drugmakers Rush to Supreme Court

The Fifth Circuit voided FDA’s 2021 mail-dispensing rule for mifepristone, banning telehealth prescribing nationwide. The Supreme Court issued an emergency stay May 14.

⚡ Cached with atec Page Cache